The US Institute of Functional Medicine is planning to open its first office in Europe. The movement is now using an individual’s genome to tackle many illnesses, often through the use of complex dietary supplements, and is big business in the USA. Per Batelson, former CEO of Capio Group and founder of international clinic chain Global Health Partner, says that it opens up a vast new market in the prevention and handling of chronic illnesses at a primary care level. Meanwhile, a German lab operator tells us that tests paid for privately, often with a genetic element, are growing in value by anything from 10% to over 35% a year.
October 5, 2012